- Home
- OST vs PHAR Comparison
OST vs PHAR Comparison
Compare OST & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- PHAR
- Stock Information
- Founded
- OST 2010
- PHAR 1988
- Country
- OST China
- PHAR Netherlands
- Employees
- OST N/A
- PHAR N/A
- Industry
- OST Industrial Machinery/Components
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- PHAR Health Care
- Exchange
- OST Nasdaq
- PHAR Nasdaq
- Market Cap
- OST 601.6M
- PHAR 718.1M
- IPO Year
- OST 2022
- PHAR N/A
- Fundamental
- Price
- OST $0.17
- PHAR $10.27
- Analyst Decision
- OST
- PHAR Strong Buy
- Analyst Count
- OST 0
- PHAR 3
- Target Price
- OST N/A
- PHAR $30.00
- AVG Volume (30 Days)
- OST 41.9M
- PHAR 4.3K
- Earning Date
- OST 08-25-2025
- PHAR 07-31-2025
- Dividend Yield
- OST N/A
- PHAR N/A
- EPS Growth
- OST N/A
- PHAR N/A
- EPS
- OST N/A
- PHAR N/A
- Revenue
- OST $38,333,251.00
- PHAR $320,708,000.00
- Revenue This Year
- OST N/A
- PHAR $13.31
- Revenue Next Year
- OST N/A
- PHAR $7.68
- P/E Ratio
- OST N/A
- PHAR N/A
- Revenue Growth
- OST 0.34
- PHAR 24.13
- 52 Week Low
- OST $0.12
- PHAR $6.65
- 52 Week High
- OST $9.40
- PHAR $12.61
- Technical
- Relative Strength Index (RSI)
- OST 24.79
- PHAR 48.21
- Support Level
- OST $0.12
- PHAR $10.46
- Resistance Level
- OST $9.40
- PHAR $11.49
- Average True Range (ATR)
- OST 0.98
- PHAR 0.37
- MACD
- OST -0.93
- PHAR -0.12
- Stochastic Oscillator
- OST 0.48
- PHAR 27.62
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.